NCT06960200

Brief Summary

Obstructive sleep apnea (OSA) is a medical condition where a person has great difficulty with breathing, or stops breathing all together, while asleep. This is a medical condition for which one of the current standard treatments is the use of a custom made dental appliance to help hold the person's airway open while asleep so that the person does not suffocate while sleeping. However, while the majority of OSA patients are able to tolerate the use of oral appliance therapy (OAT) for OSA, some patients are incomplete responders to OAT. These patients, despite having improvement, may still have a disease index above the diagnostic threshold for OSA. Phototherapy (laser therapy) has been used as a method to stiffen the soft palate and parts of the tongue to prevent their collapse. This is a type of cold laser therapy that does not cut/ablate tissue (similar to healing laser therapies). This has been shown to help with both snoring and can also help with OSA, as soft palate and tongue collapse are common areas for where OSA occurs inside the airway. A recent pilot study has shown that phototherapy on its own may be able to treat selected patients with mild, moderate, or severe OSA. To our knowledge, there are no contraindications to combining phototherapy and dental sleep appliance therapy.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
528

participants targeted

Target at P75+ for phase_2

Timeline
56mo left

Started Jan 2024

Longer than P75 for phase_2

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress34%
Jan 2024Dec 2030

Study Start

First participant enrolled

January 5, 2024

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

April 28, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 7, 2025

Completed
5.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2030

Last Updated

May 7, 2025

Status Verified

April 1, 2025

Enrollment Period

6.9 years

First QC Date

April 28, 2025

Last Update Submit

April 28, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • OSA disease index

    4 months

Study Arms (3)

Control

NO INTERVENTION

NL C3

EXPERIMENTAL
Device: Phototherapy

QN

EXPERIMENTAL
Device: Phototherapy

Interventions

Non-surgical laser therapy (phototherapy)

NL C3QN

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosed with OSA
  • incomplete treatment with OAT/MAD

You may not qualify if:

  • not diagnosed with OSA
  • using CPAP

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alberta, Edmonton, Alberta T6G 2E1

Edmonton, Canada

RECRUITING

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Interventions

Phototherapy

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Intervention Hierarchy (Ancestors)

Therapeutics

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 28, 2025

First Posted

May 7, 2025

Study Start

January 5, 2024

Primary Completion (Estimated)

December 1, 2030

Study Completion (Estimated)

December 1, 2030

Last Updated

May 7, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations